HAGAR, which develops a GWave (Glucose Wave) Technology, a sensor-enabled wearable blood glucose monitoring system, announced an $11.7 million Series B funding round led by

HAGAR, which develops a GWave (Glucose Wave) Technology, a sensor-enabled wearable blood glucose monitoring system, announced an $11.7 million Series B funding round led by